The American Society of Clinical Oncology (ASCO) and Friends of Cancer Research have drafted five US Food and Drug Administration (FDA) guidance documents focusing on cancer clinical trial eligibility criteria for patients with brain metastases  HIV/AIDS  organ dysfunction  prior and concurrent malignancies and minimum age for enrollment